Prognostic Value of the CALLY Index in Patients Undergoing Primary PCI
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
This study aims to evaluate the relationship between the admission CALLY index and short-term adverse outcomes in STEMI patients undergoing PPCI. Specifically, it seeks to determine whether the CALLY index is associated with in-hospital and 30-day complications, including heart failure, arrhythmias, reinfarction, or death. Additionally, the study will assess the association between the CALLY index and procedural success, defined by post-intervention TIMI flow, as well as the complexity of coronary artery disease using the SYNTAX score.
Eligibility criteria
Qualifiers
Diagnosis of STEMI based on 4th universal definition of myocardial infarction
Undergoing Primary PCI within guideline-recommended timeframes
Provided informed consent to participate in the study
Disqualifiers
Active infection (as detected by baseline leukocytosis on admission), autoimmune or inflammatory disease affecting CRP, albumin, or lymphocyte counts
Chronic liver disease or advanced malignancy
Patients receiving immunosuppressive therapy
Refusal to participate
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov